Our Our science-first approach drives innovation in every formulation. We combine deep research, patented extraction, and clean technology to deliver algal omega-3 products that meet global safety, purity, and performance standards. Our Algal Omega-3 Research and Innovation in India supports continuous development across the production lifecycle.
Our DSIR Certified Microalgae R&D Facility in India supports our research and innovation activities, with a focus on microalgae strain selection,
fermentation optimisation, and formulation development.
R&D certified by the Department of Scientific and Industrial Research, Government of India.
Our Algal Omega-3 Research and Innovation in India is supported by a DSIR Certified Microalgae R&D Facility in India.
Exclusive, patented extraction and formulation processes developed specifically for wild-type Indian microalgae.
Our work includes Development of Schizochytrium sp. strain in India.
Continuous innovation across the entire production lifecycle.
Our research also supports the Solvent-Free Extraction of Algal Oil in India, alongside the Development of Schizochytrium sp. strain in India.
AlgalR, a Camlin Fine Sciences company, takes a science first approach, combining research, patented extraction, and clean technology to produce algal omega-3 products that meet global safety, purity, and performance standards. Its ongoing work supports continued research and innovation in algal Omega-3 technology in India.
Yes. AlgalR’s R&D operations are certified by the Department of Scientific and Industrial Research (DSIR), Government of India, with this recognition in place since 2014. This reflects the company’s long term investment in DSIR-certified microalgae research and development in India.
Yes. Solvent free extraction is one of AlgalR’s core R&D focus areas, alongside microalgae strain selection, fermentation optimisation, and bioavailability enhancement. Its solvent-free algae extraction process helps preserve nutrient integrity while avoiding harsh chemical solvents during extraction.
AlgalR’s algal DHA and DHA plus EPA products are derived from Schizochytrium sp. microalgae, and strain selection remains one of the company’s ongoing core R&D focus areas. This Schizochytrium sp. strain research and development supports continuous strain optimisation for consistent DHA and EPA yield, purity, and quality across the product range.
AlgalR holds an exclusive patent portfolio covering extraction and formulation processes developed specifically for wild type Indian microalgae. These patented processes support the company’s ability to deliver clean label, solvent free omega-3 oils and powders at scale.
AlgalR’s ongoing R&D spans the full production lifecycle, with core focus areas including microalgae strain selection, fermentation optimisation, solvent free extraction, and bioavailability enhancement, all aimed at improving product purity, consistency, and nutritional performance.
AlgalR’s DSIR certification has been in place since 2014, reflecting more than a decade of government recognised research and development in microalgae based omega-3 science.
Because AlgalR’s algal omega-3 products come from proprietary strain research, patented extraction methods, and ongoing fermentation optimisation, the company can maintain consistent DHA purity and clean label quality across its oil, powder, and capsule formats, something that is harder to guarantee with less research driven, commodity sourced omega-3.
The research carried out by AlgalR feeds directly into its commercial product range, including Algal DHA Oil and Powder, Algal Omega-3 (DHA+EPA) Oil and Powder, and vegetarian softgel capsules, as well as its custom formulation and private label services for partner brands.
You can contact AlgalR directly at +91 94898 47425, +91 88701 64876, or salesanpl@camlinfs.com to discuss R&D collaboration, custom formulation projects, or technical documentation requests.
age.
CFS-AlgalR delivers high-quality, algae-based omega-3 ingredients tailored for human and animal nutrition.
